Financials

  • Market Capitalization 523.81 M
  • Employee 149
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.58
市销率
-6 934.07

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2876
CABA
Cabaletta Bio, Inc. - Common Stock
3.23 USD-4.44%0.00%+18.75%+113.91%547.63 M USD
2894
ENTX
Entera Bio Ltd. - Ordinary Shares
3.04 USD-1.30%-8.71%-5.59%+52.00%526.35 M USD
2910
EDIT
Editas Medicine, Inc. - Common Stock
3.32 USD+0.61%+7.79%+27.69%+25.28%509.89 M USD
2919
CCCC
C4 Therapeutics, Inc. - Common Stock
3.89 USD-5.12%-3.23%+12.75%+53.75%478.57 M USD